These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25120750)

  • 1. Clinical value of CD133 and nestin in patients with glioma: a population-based study.
    Dahlrot RH; Hansen S; Jensen SS; Schrøder HD; Hjelmborg J; Kristensen BW
    Int J Clin Exp Pathol; 2014; 7(7):3739-51. PubMed ID: 25120750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
    Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
    J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
    Wu B; Sun C; Feng F; Ge M; Xia L
    J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the clinical value of cancer stem cell markers in gliomas?
    Dahlrot RH; Hermansen SK; Hansen S; Kristensen BW
    Int J Clin Exp Pathol; 2013; 6(3):334-48. PubMed ID: 23412423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell marker CD133 affects clinical outcome in glioma patients.
    Zeppernick F; Ahmadi R; Campos B; Dictus C; Helmke BM; Becker N; Lichter P; Unterberg A; Radlwimmer B; Herold-Mende CC
    Clin Cancer Res; 2008 Jan; 14(1):123-9. PubMed ID: 18172261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors.
    Beier D; Wischhusen J; Dietmaier W; Hau P; Proescholdt M; Brawanski A; Bogdahn U; Beier CP
    Brain Pathol; 2008 Jul; 18(3):370-7. PubMed ID: 18371181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
    Li MW; Niu CS
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis.
    Han M; Guo L; Zhang Y; Huang B; Chen A; Chen W; Liu X; Sun S; Wang K; Liu A; Li X
    Mol Neurobiol; 2016 Jan; 53(1):720-727. PubMed ID: 25589004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors.
    Lan J; Huang B; Liu R; Ju X; Zhou Y; Jiang J; Liang W; Shen Y; Li F; Pang L
    Int J Clin Exp Pathol; 2015; 8(10):12621-33. PubMed ID: 26722452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.
    Tamura K; Aoyagi M; Ando N; Ogishima T; Wakimoto H; Yamamoto M; Ohno K
    J Neurosurg; 2013 Nov; 119(5):1145-55. PubMed ID: 23991844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic value of JAM-A in gliomas.
    Rosager AM; Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Lathia JD; Kristensen BW
    J Neurooncol; 2017 Oct; 135(1):107-117. PubMed ID: 28677106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does proximity to the subventricular zone and expression of CXCR-4 and nestin affect prognosis in high-grade glioma?
    Arzoglou V; Tsitlakidis A; Foroglou N; Polyzoidis K; Makri S; Patsalas I
    Br J Neurosurg; 2018 Dec; 32(6):614-618. PubMed ID: 30282472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periostin is a new potential prognostic biomarker for glioma.
    Tian B; Zhang Y; Zhang J
    Tumour Biol; 2014 Jun; 35(6):5877-83. PubMed ID: 24719188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
    Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
    Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathological characteristics of glioma stem cell niches.
    He H; Li MW; Niu CS
    J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas.
    He J; Shan Z; Li L; Liu F; Liu Z; Song M; Zhu H
    Oncol Rep; 2011 Nov; 26(5):1305-13. PubMed ID: 21769436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
    Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
    Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.
    Rebetz J; Tian D; Persson A; Widegren B; Salford LG; Englund E; Gisselsson D; Fan X
    PLoS One; 2008 Apr; 3(4):e1936. PubMed ID: 18398462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro neurosphere formation correlates with poor survival in glioma.
    C Jayakrishnan P; H Venkat E; M Ramachandran G; K Kesavapisharady K; N Nair S; Bharathan B; Radhakrishnan N; Gopala S
    IUBMB Life; 2019 Feb; 71(2):244-253. PubMed ID: 30393962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.